Login / Signup

Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D.

Frida WelanderHenrik RenlundEmöke DiményHenrik HolmbergAnders Själander
Published in: Clinical kidney journal (2022)
Warfarin treatment is associated with a lower risk of ischaemic stroke for patients with NVAF and G3, G4 and G5D at the cost of a higher risk of major bleeding for G4-G5D. Existing observational data are conflicting, stressing the need for RCTs on warfarin compared with no treatment in G4-G5D. Awaiting RCTs, it seems reasonable to treat selected patients on dialysis and NVAF with warfarin.
Keyphrases